Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america

Juan Camilo Sarmiento-Monroy1, Jenny Amaya-Amaya, Juan Sebastián Espinosa-Serna

  • 1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, 111221 Bogotá, Colombia.

Arthritis
|November 30, 2012
PubMed

Insights

Cardiovascular disease (CVD) is common in Latin American rheumatoid arthritis (RA) patients, affecting 35.3%. Nontraditional risk factors like inflammation and genetics contribute, highlighting the need for targeted public health strategies.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) significantly worsens prognosis for rheumatoid arthritis (RA) patients.
  • Identifying nontraditional risk factors for CVD in specific populations, like Latin Americans (LA), is crucial.
  • A literature gap exists regarding CVD in RA patients within LA and the Caribbean.

Purpose of the Study:

  • To systematically review existing literature on cardiovascular risk factors and outcomes in rheumatoid arthritis patients in Latin America.
  • To determine the prevalence of CVD in this specific ethnic subgroup.
  • To identify associated traditional and nontraditional risk factors.

Main Methods:

  • A systematic literature review was conducted by two independent, blinded reviewers.
  • Searches were performed across major scientific databases: PubMed, LILACS, SciELO, and Virtual Health Library.
  • Studies focusing on cardiovascular risk factors or outcomes in Latin American RA patients were included.

Main Results:

  • Out of 10,083 retrieved studies, 16 articles met the inclusion criteria.
  • The prevalence of CVD among Latin American RA patients was found to be 35.3%.
  • Nontraditional risk factors identified include HLA-DRB1 shared epitope alleles, rheumatoid factor, chronic inflammation markers, prolonged RA duration, steroid use, familial autoimmunity, and thrombogenic factors.

Conclusions:

  • Data on CVD in RA patients within Latin America is currently limited.
  • There is a need for comprehensive cardiovascular risk factor evaluation in Latin American RA patients.
  • Developing targeted public health policies is essential to reduce CVD morbidity and mortality in this population.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...